1. Ader, R., Felten, D. and Cohen, N. (1990) Interactions between the brain and the immune system. Ann. Rev. Pharmacol. Toxicol. 30, 561–602.
2. Bidlack, J.M., Saripalli, L.D. and Lawrence, D.M.P. (1992) Kappa-opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmacol. 227, 257–265.
3. Bossie, A., Brooks, K.H., Krammer, P.H. and Vitetta, E.S. (1987) Activation of murine B cells from different tissues with different mitogens. II. Isotype distribution of secreted immunoglobulins in the presence and absence of IL-4-containing T cell supernatants. J. Mol. Cell. Immunol. 3, 221–226.
4. Brooks, K.H. and Vitetta, E.S. (1987) Activation of murine B cells with Salmonella Typhimurium mitogen (STM), lipopolysaccharide (LPS), and dextran sulfate (DxS). I. Cell-cycle analysis and induction of cytoplasmic immunoglobulin. J. Mol. Cell. Immunol. 3, 215–219.
5. Brown, S.L. and Van Epps, D.E. (1986) Opioid peptides modulate production of interferon-gamma by human mononuclear cells. Cell. Immunol. 103, 19–26.